ARCHIVES

Guideline Revisions or Outstanding Investigator Grant Still Controversial

This article is from The Cancer Letter archive.

Vol. 09 No. 47 | December 9, 1983

Download PDF Visit The Full Archive

Related Articles

NCI Names Brawly Director of Office of Special Populations

June 21, 1996

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004

Norton Succeeds Einhorn As ASCO President, Colorado’s Paul Bunn Is President-Elect.

May 11, 2001

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

BSA Approves 3 Concepts For Grants Worth $44 Million.

November 30, 2001